Tag: Medicare drug negotiation

How Buyers Use Generic Competition to Negotiate Lower Drug Prices

How Buyers Use Generic Competition to Negotiate Lower Drug Prices

Buyers like Medicare use the presence of generic drugs to negotiate lower prices for brand-name medications. Generic competition drives prices down by over 90% in many cases, making it a key tool for controlling drug costs.

Recent Posts

Managing Dizziness After Surgery: Tips and Facts
Mar, 11 2025
Managing Dizziness After Surgery: Tips and Facts

Dizziness after surgery can be a common yet disorienting experience. This piece explores practical ways to manage dizziness effectively, delving into causes and offering helpful tips for recovery. Understanding how to navigate these post-surgery effects is key to a smoother healing process. Learn what to expect and how to ease this sensation in everyday life.

Insurance Changes and Generic Switching: Navigating Formulary Updates in 2025
Jan, 23 2026
Insurance Changes and Generic Switching: Navigating Formulary Updates in 2025

Understand how 2025 Medicare Part D formulary updates are forcing generic and biosimilar switches, what drugs are affected, and how to protect your coverage before January 1.

Cleocin Gel (Clindamycin) vs. Other Topical Acne Treatments: A Practical Comparison
Sep, 28 2025
Cleocin Gel (Clindamycin) vs. Other Topical Acne Treatments: A Practical Comparison

A clear comparison of Cleocin Gel (clindamycin) with other topical acne treatments, covering how they work, price, side effects, and tips for choosing the best option.

HPV-Related Cancers: Throat, Anal, and How to Prevent Them
Dec, 7 2025
HPV-Related Cancers: Throat, Anal, and How to Prevent Them

HPV causes thousands of throat and anal cancers each year in the U.S., with rising rates among men. Vaccination is the most effective way to prevent these cancers - yet coverage remains too low. Learn how HPV leads to cancer and what you can do to stop it.

180-Day Exclusivity: How Patent Challenges Delay Generic Drug Entry
Dec, 3 2025
180-Day Exclusivity: How Patent Challenges Delay Generic Drug Entry

The 180-day exclusivity rule under the Hatch-Waxman Act was meant to speed up generic drug entry-but now it often delays it. Learn how patent challenges, FDA rules, and corporate strategy keep prices high and patients waiting.